Trimetazidine: abnormal movements and hallucinations. Should be withdrawn from the market.
D005602:France; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D009069:Movement Disorders / Q000209:etiology*; D014292:Trimetazidine / Q000009:adverse effects*
D014292:Trimetazidine